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Abstract
Background Muscle wasting and weakness in Duchenne muscular dystrophy (DMD) causes severe locomotor limitations and
early death due in part to respiratory muscle failure. Given that current clinical practice focuses on treating secondary compli-
cations in this genetic disease, there is a clear need to identify additional contributions in the aetiology of this myopathy for
knowledge-guided therapy development. Here, we address the unresolved question of whether the complex impairments ob-
served in DMD are linked to elevated mitochondrial H2O2 emission in conjunction with impaired oxidative phosphorylation.
This study performed a systematic evaluation of the nature and degree of mitochondrial-derived H2O2 emission and mitochon-
drial oxidative dysfunction in a mouse model of DMD by designing in vitro bioenergetic assessments that attempt to mimic
in vivo conditions known to be critical for the regulation of mitochondrial bioenergetics.
Methods Mitochondrial bioenergetics were compared with functional and histopathological indices of myopathy early in
DMD (4 weeks) in D2.B10-DMDmdx/2J mice (D2.mdx)—a model that demonstrates severe muscle weakness. Adenosine di-
phosphate’s (ADP’s) central effect of attenuating H2O2 emission while stimulating respiration was compared under two models
of mitochondrial-cytoplasmic phosphate exchange (creatine independent and dependent) in muscles that stained positive for
membrane damage (diaphragm, quadriceps, and white gastrocnemius).
Results Pathway-speciﬁc analyses revealed that Complex I-supported maximal H2O2 emission was elevated concurrent with
a reduced ability of ADP to attenuate emission during respiration in all three muscles (mH2O2: +17 to +197% in D2.mdx vs. wild
type). This was associated with an impaired ability of ADP to stimulate respiration at sub-maximal and maximal kinetics (17
to 72% in D2.mdx vs. wild type), as well as a loss of creatine-dependent mitochondrial phosphate shuttling in diaphragm and
quadriceps. These changes largely occurred independent of mitochondrial density or abundance of respiratory chain com-
plexes, except for quadriceps. This muscle was also the only one exhibiting decreased calcium retention capacity, which indi-
cates increased sensitivity to calcium-induced permeability transition pore opening. Increased H2O2 emission was
accompanied by a compensatory increase in total glutathione, while oxidative stress markers were unchanged. Mitochondrial
bioenergetic dysfunctions were associated with induction of mitochondrial-linked caspase 9, necrosis, and markers of atrophy
in some muscles as well as reduced hindlimb torque and reduced respiratory muscle function.
Conclusions These results provide evidence that Complex I dysfunction and loss of central respiratory control by ADP and
creatine cause elevated oxidant generation during impaired oxidative phosphorylation. These dysfunctions may contribute
to early stage disease pathophysiology and support the growing notion that mitochondria are a potential therapeutic target
in this disease.
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Introduction
Duchenne muscular dystrophy (DMD) is a debilitating disease
that causes progressive muscle atrophy and weakness. Immo-
bility related to skeletal muscle weakness manifests in child-
hood while eventual respiratory muscle failure causes ~40%
of deaths in early adulthood.1,2 Inherited mutations in the
gene dystrophin cause a loss in the normal function of this
sarcolemmal-cytoskeletal protein.3 Subsequent disruptions
to cell membrane stability and cytoskeletal organization are
linked to increased cytosolic calcium, oxidative stress, and cell
death that are cellular hallmarks of this disease.2,4 Moreover,
a highly pro-inﬂammatory environment worsens the myopa-
thy.5 In this light, it has been proposed that mitochondrial
dysfunctions arise from these multiple cellular stressors and
may even reciprocate as a direct inﬂuence on muscle ﬁbre
degeneration.6–8
Given that there is no cure for DMD, identifying second-
ary contributions has been a major focus for guiding ther-
apy development.9 Indeed, current clinical practice targets
inﬂammation rather than the genetic mutation itself.9 To
this end, compounds that target mitochondria have attenu-
ated the myopathy in mouse models of this disease. For ex-
ample, the quinone-based idebenone—an electron
shuttler10—improved cardiac function and exercise perfor-
mance in mice11 as well as cardiac and respiratory function
in DMD patients.12–14 These drugs were developed based in
part on pre-clinical evidence of impaired mitochondrial re-
spiratory function in skeletal muscle of mouse models of
DMD8,15,16 and of humans.15,17 As such, identifying addi-
tional mitochondrial abnormalities could guide further ther-
apy development.
As mitochondria naturally emit H2O2 during oxidative phos-
phorylation, impairments to efﬁcient electron transport
through the electron transport system could contribute to ex-
cessive H2O2 emission. To our knowledge, only one study to
date has compared mitochondrial-speciﬁc H2O2 emission in
dystrophin-deﬁcient muscle to wild type (WT).8 This well-
designed investigation demonstrated the expected impair-
ment in oxidative phosphorylation and calcium retention ca-
pacity (an index of permeability transition linked to
apoptosis), but also reported a surprising decrease in mito-
chondrial H2O2 emission in C57bl/10-mdx mice. However, a
concomitant increase in oxidant buffering capacity was noted
and could represent a compensatory response in this mouse
model, suggesting that mitochondrial H2O2 may indeed be el-
evated in vivo, particularly in relation to impaired oxidative
phosphorylation.8 Given these observations, it is uncertain if
mitochondrial H2O2 is elevated in DMD.
The design of in vitro assessments of both mitochondrial
H2O2 emission and respiration can be essential for capturing
the degree of bioenergetic dysfunction in a disease. It is
well established that adenosine diphosphate (ADP) lowers
mitochondrial H2O2 emission while stimulating oxidative
phosphorylation by virtue of reduced premature electron
slip from the electron transport system.18 As such, it is pos-
sible that mitochondrial dysfunction could manifest as a loss
of central control by ADP to govern both H2O2 emission and
respiration during oxidative phosphorylation. Furthermore,
it has also been proposed that creatine is essential for opti-
mizing ADP stimulation of oxidative phosphorylation and at-
tenuation of H2O2 emission. This is believed to occur
through a process of ‘high energy phosphate shuttling’ facil-
itated by mitochondrial creatine kinase (mtCK) (Figure 2)19–
21,23 whereby the rapidly diffusing phosphocreatine export
ultimately accelerates mitochondrial matrix ADP cycling, re-
duces H2O2 emission, and stimulates oxidative phosphoryla-
tion.22,24 Overall, given the complexity of how bioenergetics
are governed by ADP and creatine, it follows that a re-
design of in vitro protocols may reveal the extent to which
dystrophin deﬁciency impairs the governance of mitochon-
drial H2O2 emission during oxidative phosphorylation.
In this investigation, we determined the precise mecha-
nism and degree of mitochondrial dysfunction in dystrophic
locomotor muscles as well as respiratory muscle. The ability
of ADP to attenuate H2O2 emission during oxidative phos-
phorylation was determined in the D2.B10-DMDmdx/2J (D2.
mdx) mouse. This model demonstrates severe muscle atro-
phy and weakness that more closely mimics human disease
progression compared with the classic C57bl/10-mdx mice
due to attenuated muscle regeneration arising from a natural
mutation in TGF-β4 binding protein 4 in the background D2A
strain.25,26 By employing these methodological approaches,
we provide new evidence that a central impairment in ADP
and creatine’s control of bioenergetics is linked speciﬁcally
to increased Complex I-supported H2O2 concurrent with im-
paired respiration. This observation is ubiquitous across loco-
motor and respiratory muscles and may be related to muscle
weakness, atrophy, and cellular pathology in very early stages
of myopathy in D2.mdx.
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Materials and methods
Animal care
The 4-week-old D2.mdx animals originated from a colony
maintained at York University (Toronto, Canada) and sourced
from Jackson Laboratories (Bar Harbor, USA). Post-weaning
(28 days) animals were housed with male littermates until
they underwent functional testing, at which time they were
singly housed. Four-week-old DBA/2J WT mice were obtained
directly from Jackson Laboratories because of breeding chal-
lenges with this strain. Upon arrival, DBA/2J mice were singly
housed and given a minimum of 72 h to acclimatize before
experiments were performed. All animals were provided ac-
cess to standard chow and water ad libitum. All experiments
and procedures were approved by the Animal Care Commit-
tee at York University (AUP Approval Number 2016-18) in ac-
cordance with the Canadian Council on Animal Care.
Body composition and functional assays
Timeline of measurements
A variety of tests were performed on mice before surgical re-
moval of muscle for in vitro analyses. Speciﬁcally, 2 days prior
to surgery, whole body functional testing (cage hang time,
forelimb grip strength, and voluntary wheel running) was per-
formed. On the day of surgery, prior to muscle harvest, ani-
mals underwent a micro-computed tomography scan for
muscle volume (see below). Because of tissue limitation, a
separate set of animals was used for histochemistry and
transmission electron microscopy analysis. Finally, in order
to avoid confounding inﬂuences of force/pressure measure-
ments on mitochondrial bioenergetic analysis, a separate
set of animals was used to assess oesophageal pressure
transduction and in vivo force production.
In vivo micro-computed tomography scans
In vivo body scans were performed using micro-computed to-
mography (SkyScan 1278, Bruker-microCT, Kontich, Belgium).
Mice were anaesthetized and maintained with isoﬂurane an-
aesthetic during the scans. Mice were laid supine with
hindlimbs extended and secured in place. Body scans were
completed with a 100 μm resolution using a 0.5 mm alumin-
ium ﬁlter at 50 kV and 996 μA, with a 30 ms exposure time
and a 0.75° rotation step. Following scans, lower limb muscle
volume was analysed by ﬁrst reconstructing the image using
NRecon (software version 1.7.0.4, Bruker-microCT). Recon-
structed images were then imported into CTAn (software ver-
sion 1.15.4.0, Bruker-microCT) where the region of interest
was selected and analysed. The region of interest for
hindlimb muscle volume was landmarked from the top of
Figure 1 Evaluation of muscle wasting and weakness in D2.mdx mice. Body weight (A, n = 8–10), microCT analysis of lower limb muscle volume (B,
n = 6–7), and muscle-speciﬁc cross-sectional area (CSA) using wheat germ stain for diaphragm (n = 6) and haematoxylin and eosin (H&E) for Quad
(n = 3) and WG (n = 3) (C). Whole body muscle damage was quantiﬁed by serum creatine kinase (CK) activity (D, n = 5–7). Indices of muscle function
were assessed by 24 h voluntary wheel running (E, n = 13–14), cage hang time (F, n = 10–11), and forelimb grip strength (G, n = 9–11). Lower hindlimb
force production was assessed in vivo through torque–frequency relationship (H) followed by a max-torque challenge (I, n = 5–6). Respiratory function
in vivo was assessed through oesophageal pressure transduction to determine maximal inspiratory pressure (PIocc) (J, n = 7). Results represent
mean ± SEM; #P < 0.05 main effect compared with wild type (WT); *P < 0.05 compared with WT.
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the patella to the ankle joint and was quantiﬁed by setting
thresholds for fat-free mass (76–102), expressed as volume
(mm3) of lean mass/g body weight.
Voluntary wheel running
Animals were placed in individual cages equipped with a
locked 14 cm diameter running wheel and rotation counter
(VDO m3 bike computer, Mountain Equipment Co-Op, Van-
couver, Canada). After 24 h of acclimatization, wheels were
unlocked, and distance run over 24 h was recorded.
Cage hang time
Animals were placed on top of a metal cage lid ~30 cm above
soft bedding and positioned so that all four limbs grasped the
cage. The cage lid was inverted so that the mouse was hang-
ing, and a timer was started. Cage hang time was recorded
for a maximum of 180 s. Animals that fell off prior to 180 s
were given 3 min to recover before a second trial and third
trial. The maximum hanging time for each animal was
recorded.27
Forelimb grip strength
A metal grid was attached to a force transducer (Mark 10 Dig-
ital Force Gauge, Copiague, NY) set to peak tension mode.
The force transducer was placed on the edge of a tabletop
allowing the grid to extend past the table. Mice were re-
moved from their cages by the tail and brought towards the
grid until such time that the mice grasped the grid with their
forepaws. Upon grasping, animals were pulled away from the
grid until their grasp was broken. Peak tension was recorded,
and the trial was repeated twice more. If the animal did not
show resistance to the experimenter, the trial was not re-
corded. Maximum peak tension from the best of three trials
was used for analysis.27
Oesophageal pressure transduction
Oesophageal pressure measurements were performed as
previously described.28 Brieﬂy, mice were anesthetized with
an isoﬂurane/oxygen mix (2%:100%), and body temperature
was maintained at 37°C. Mice were intubated using a 20-
gauge angiocatheter (Becton, Dickinson and Company) to
maintain an open/unobstructed airway. Compressible tubing
was attached to the angiocatheter to facilitate inducible air-
way occlusions. Oesophageal pressure (Peses) was measured
with a 1.2F catheter (Transonic) recorded on LabScribe2 soft-
ware (iWorx) and analysed with Spike2 software (Cambridge
Electronic Design). Immediately after 2 min of baseline Pes re-
cording, the trachea was occluded, and Pes was monitored for
changes. Tracheal occlusions were initiated at end expiratory
Figure 2 Schematic representation of energy transfer between mitochondria and cytosol. The leading model for energy exchange involves a creatine-
independent (Cr) and creatine-dependent (+Cr) pathway. The left side depicts the Cr pathway whereby ADP/ATP transfer occurs solely through
diffusion across voltage-dependent anion carrier (VDAC) on the outer mitochondrial membrane and adenosine nucleotide translocase (ANT) on the
inner mitochondrial membrane. The right side depicts the +Cr pathway where, in the presence of Cr, energy transfer is facilitated by mitochondrial
creatine kinase (mtCK) through the transfer of the phosphate group from ATP to Cr, producing phosphocreatine (PCr) and ADP in the inner membrane
space. The PCr is exported via VDAC into the cytosol while the ADP is directly recycled back via ANT into the mitochondrial matrix. Figure adapted from
Aliev et al., 2011, Guzun et al., 2012, Myer et al., 1984, and Wallimann et al., 2011.19–22
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volume to ensure consistency of the diaphragm length–
tension relationship. Maximum inspiratory pressure (PIocc)
was evaluated after 30 s of occlusion when pressure genera-
tion reached a plateau.
In vivo hindlimb force production
In vivo force production of the hindlimb plantarﬂexor muscles
was partially adapted from previous methods.29 In brief, mice
were anesthetized with isoﬂurane and placed on a platform
maintained at 37°C. The left foot was secured to a footplate
attached to an Aurora Scientiﬁc 305C muscle lever (Aurora,
Ontario, Canada) so that the ankle’s axis of rotation coincided
with that of the servomotor shaft. The knee was clamped in
place such that the knee and ankle angles were both 90°.
Contraction of the plantarﬂexors was controlled through per-
cutaneous stimulation of the sciatic nerve. Peak isometric
torque was determined by varying the voltage delivered to
the sciatic nerve at a frequency of 60 Hz and 0.2 ms square
wave pulse. Torque as a function of stimulation frequency
was measured during seven isometric contractions at varying
stimulation frequencies (40, 60, 80, 100, 120, 140, and
160 Hz). Maximum torque produced during the torque–
frequency protocol was recorded and compared between
groups.
Serum creatine kinase
Blood was collected through cardiac puncture and allowed to
clot at room temperature for 30 min. Following clotting,
blood was spun at 1000 g for 10 min, and serum was col-
lected. Creatine kinase activity was measured
spectroﬂuorometrically (QuantaMaster 80, HORIBA Scientiﬁc,
Edison, NJ, USA) based on the autoﬂuorescence of NADPH
(excitation: 340 nm; emission: 450 nm) using the Pointe Sci-
entiﬁc Serum Creatine Kinase kit (Pointe Scientiﬁc, Canton,
MI, USA). Creatine kinase activity (U/L) was calculated from
the rate of NADPH production (F/min) applied to a standard
curve produced under the same conditions and normalized
to volume dilution.
Selection of muscles for analyses
A subset of mice (n = 2) were injected i.p. with 1% Evans Blue
Dye (Sigma, St Louis, MO, USA) (w/v) in phosphate-buffered
saline (pH 7.5) sterilized by passage through a Millex®-GP
0.22 μm ﬁlter (Millipore, Bedford, MA, USA). Sixteen hour
post injection, animals were sacriﬁced and muscles were har-
vested to allow for the visual inspection of dye uptake. We
selected skeletal muscles that stained positive for Evans Blue
Dye to ensure mitochondrial bioenergetics were assessed in
muscle displaying a severe phenotype (Supporting Informa-
tion, Figure S1). The vastus intermedius of the quadriceps
(Quad), composed of IIA, IIX, and IIB ﬁbres,30 and white
gastrocnemius (WG), composed of predominantly of IIB ﬁ-
bres,30 were selected in addition to diaphragm, which also
showed substantial membrane damage.
Mitochondrial bioenergetic assessments
Preparation of permeabilized muscle ﬁbre bundles
This technique is partially adapted from previous methods
and has been described elsewhere.31–34 Brieﬂy, muscles were
removed from mice during anaesthesia with isoﬂurane. We
performed all tissue harvests in approximately half an hour
to minimize the chance of negative effects of isoﬂurane on
mitochondrial function as has been reported with longer
6 h durations.35 The Quad and WG from the non-stimulated
leg as well as a strip of diaphragm were removed and imme-
diately placed in ice-cold BIOPS, containing (in mM) 50 MES
Hydrate, 7.23 K2EGTA, 2.77 CaK2EGTA, 20 imidazole, 0.5 di-
thiothreitol, 20 taurine, 5.77 ATP, 15 PCr, and 6.56 MgCl2·6
H2O (pH 7.1). Each muscle was trimmed of connective tissue
and fat and divided into several small muscle bundles (~2–
7 mm, 1.0–2.5 mg wet weight). Each bundle was gently sep-
arated along the longitudinal axis to form bundles that were
treated with 40 μg/mL saponin in BIOPS on a rotor for
30 min at 4°C. Bundles destined for Complex I and pyruvate
dehydrogenase complex mitochondrial H2O2 emission
(mH2O2) measurements (described below) were also treated
with 35 μM 2,4-dinitrochlorobenzene (CDNB) during the per-
meabilization step to deplete glutathione and allow for de-
tectable rates of mH2O2.
36 Following permeabilization, the
permeabilized muscle ﬁbre bundles (PmFB) were divided into
three groups: (i) bundles intended for high-resolution respi-
rometry were placed in MiR05 containing (in mM) 0.5 EGTA,
10 KH2PO4, 3 MgCl2·6 H2O, 60 K-lactobionate, 20 Hepes, 20
Taurine, 110 sucrose, and 1 mg/mL fatty acid free BSA
(pH 7.1) while (ii) bundles intended for mH2O2 were placed
in Buffer Z containing (in mM) 105 K-MES, 30 KCl, 10 KH2PO4,
5 MgCl2·6 H2O, 1 EGTA, and 5 mg/mL BSA (pH 7.4). PmFB
were washed on a rotor at 4°C in MiR05 or Buffer Z until
the measurements were initiated. (iii) Bundles intended for
calcium retention capacity were placed in Buffer Y + 1 mM
EGTA containing (in mM) 250 sucrose, 10 tris–HCl, 20 tris-
base, 10 KH2PO4, and 0.5 mg/mL BSA and washed on a rotor
at 4°C for 10 min. PmFB were then transferred to a second
wash of Buffer Y + 10 μM blebbistatin (BLEB, see below)
and were washed on a rotor at 4°C until measurements were
initiated. Following permeabilization and washing, all mito-
chondrial bioenergetic measurements were performed in
the same order from one animal to another and between
groups to ensure consistent durations of the wash step.
Mitochondrial respiration
High-resolution O2 consumption measurements were con-
ducted in 2 mL of respiration medium (MiR05) using the
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Oroboros Oxygraph-2k (Oroboros Instruments, Corp., Inns-
bruck, Austria) with stirring at 750 rpm at 37°C.33,34,37–39 Res-
piration medium contained 20 mM creatine to saturate mtCK
or no creatine to prevent the activation of mtCK.37,40 A third
condition of 13.9mM PCr and 9.1mM Cr was used to provide
an equilibrium across mtCK as occurs in skeletal muscle at
rest in vivo.41 For ADP-stimulated respiratory kinetics, stan-
dard procedures to determine complexes I and II-supported
respiration were employed.39 5 mM pyruvate, accompanied
by 2 mM malate, was added as Complex I-speciﬁc substrates
(via generation of NADH to saturate electron entry into Com-
plex I) followed by a titration of sub-maximal ADP (25 and
500 μM) and maximal ADP (5 mM). Cytochrome c was added
to test for mitochondrial membrane integrity, with all exper-
iments demonstrating <10% increase in respiration. Finally,
succinate (20 mM) was then added to saturate electron entry
into Complex II. All experiments were conducted in the pres-
ence of 5 μM BLEB in the assay media to prevent spontane-
ous contraction of PmFB, which has been shown to occur in
response to ADP at 37°C that alters respiration rates.37,38,42
Each protocol was initiated with a starting [O2] of ~350 μM
and was completed before the oxygraph chamber [O2]
reached 150 μM as done previously.33,34,37–39 Polarographic
oxygen measurements were acquired in 2 s intervals with
the rate of respiration derived from 40 data points and
expressed as pmol/s/mg wet weight. PmFB were weighed in
~1.5 mL of tared BIOPS (ATP-containing relaxing media) to
ensure PmFB remained relaxed.
Mitochondrial H2O2 emission (mH2O2)
mH2O2 was determined ﬂuorometrically (QuantaMaster 40,
HORIBA Scientiﬁc) in a quartz cuvette with continuous stirring
at 37°C, in 1 mL of Buffer Z supplemented with 10 μM
Amplex Ultra Red, 0.5 U/mL horseradish peroxidase, 1 mM
EGTA, 40 U/mL Cu/Zn-SOD1, 5 μM BLEB, and 20 mM Cr.
Site-speciﬁc induction of mH2O2 was measured through the
addition of either 10 mM pyruvate and 2 mM malate (NADH,
Complex I), 10 mM succinate (FADH2, Complex I via reverse
electron ﬂux from Complex II) or 2.5 μM antimycin A (Com-
plex III). Additionally, using 0.5 μM rotenone, a Complex I in-
hibitor, plus 10 mM pyruvate, electron slip speciﬁc to
pyruvate dehydrogenase complex was also measured in
CDNB-treated ﬁbres as noted earlier.36 Following the induc-
tion of State II mH2O2 by Complex I and Complex II sub-
strates, a titration of ADP was added to progressively
attenuate mH2O2. Complexe I and II-supported mH2O2 were
repeated with no creatine in the assay buffer to compare
ADP’s effects without mtCK-mediated phosphate shuttling.
All measurements were made in the presence of 1 μM BLEB
to prevent ADP-induced rigour as described earlier. The rate
of mH2O2 emission was calculated from the slope (F/min),
from a standard curve established with the same reaction
conditions and normalized to ﬁbre bundle dry weight, or
citrate synthase content determined by western blot in mus-
cle sampled from the same mouse as bioenergetics.
Mitochondrial calcium retention capacity
This assay is partially adapted from methods previously de-
scribed.43 Mitochondrial calcium retention capacity measure-
ments were completed spectroﬂuorometrically
(QuantaMaster 80, HORIBA Scientiﬁc) in a cuvette with con-
tinuous stirring at 37°C, in 300 μL of Buffer Y containing
1 μM Calcium Green-5N (Invitrogen), 2 μM thapsigargin,
5 mM 2-deoxyglucose, 2 U/mL hexokinase, 20 mM creatine,
5 μM BLEB, and 40 μM EGTA. Prior to the initiation of each
experiment, the cuvette was placed on a stir plate with
500 μL water and 10 mM EGTA. The water was then aspi-
rated from the cuvette but not rinsed, leaving the EGTA coat-
ing on the cuvette walls to chelate any residual Ca2+ in the
assay buffer. Minimum ﬂuorescence was obtained following
the addition of the PmFB and 5mM glutamate +2mMmalate
to the assay buffer. Calcium uptake was then initiated by a
single 8 nmol pulse of CaCl2. Subsequent 4 nmol pulses of
Ca2+ were added until mitochondrial permeability transition
pore (PTP) opening was evident. Two 0.5 mM pulses of Ca2+
were then added to saturate the ﬂuorophore and establish
a ﬂuorescent maximum. All experiments were conducted at
37°C. Changes in free Ca2+ in the cuvette during mitochon-
drial Ca2+ uptake were then calculated using the known Kd
for Calcium Green-5N and the equations established for cal-
culating free ion concentrations using ion-sensitive
ﬂuorophores.44 After the experiments, the ﬁbres were rinsed
in double deionized H2O, lyophilized in a freeze-dryer
(Labconco, Kansas City, MO, USA) for >4 h and weighed on
a microbalance (Sartorius Cubis Microbalance, Gottingen,
Germany).
In vitro muscle and blood analyses
Caspase activity
Enzymatic activities of caspase 3 and caspase 9 were mea-
sured ﬂuorometrically using substrates Ac-DVED-AMC and
Ac-LEHD-AMC (Enzo Life Sciences, Farmingdale, NY) as previ-
ously described.45,46
Transmission electron microscopy
Fresh plantaris tissue was immediately ﬁxed in 2% (v/v) glu-
taraldehyde in 0.1 mol/L sodium cacodylate buffer and proc-
essed as described previously.47 Eight representative
micrographs from a unique ﬁbre containing a portion of the
subsarcolemmal region adjacent to the nucleus with most
of the image containing the intermyoﬁbrillar area were ac-
quired at ×15 000 magniﬁcation. Quantiﬁcation was achieved
using the Nikon Elements software by manually outlining mi-
tochondria and converting these to actual size using a calibra-
tion grid.48
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Glutathione
Glutathione was assessed as previously described.49 GSH was
assessed by UV-HPLC monitoring of NEM-GSH while GSSG
was assessed by ﬂuorescent-HPLC by tracking O-pthalymide
(OPA, Sigma-Aldrich, Oakville, Canada) tagged GSH through
a ﬂow-through cuvette following GSSG conversion to GSH
(FireﬂySci 8830, NY, USA) in a QuantaMaster 40 spectroﬂuo-
rometer (HORIBA Scientiﬁc). All values were referenced to
protein concentration and reported in μmol/g protein.
Western blotting
An aliquot of frozen Quad, WG, and diaphragm (10–30 mg)
from each animal was homogenized in a plastic
microcentrifuge tube with a tapered teﬂon pestle in ice-cold
buffer containing (mm) 40 Hepes, 120 NaCl, 1 EDTA, 10
NaHP2O7·10H2O pyrophosphate, 10 β-glycerophosphate, 10
NaF, and 0.3% CHAPS detergent (pH 7.1 adjusted using
KOH). Protein concentrations were determined using a
bicinchoninic acid (BCA) assay (Life Technologies, Carlsbad,
CA, USA). Fifty μg of denatured and reduced protein was sub-
jected to 6–12% gradient SDS-PAGE followed by transfer to
low-ﬂuorescence polyvinylidene diﬂuoride membrane. Mem-
branes were blocked with LI-COR Odyssey Blocking Buffer (LI-
COR, Lincoln NE, USA) and immunoblotted overnight (4°C)
with antibodies speciﬁc for each protein. A commercially
available monoclonal antibody was used to detect electron
transport chain proteins (rodent OXPHOS Cocktail,
ab110413; Abcam, Cambridge, UK, 1:250 dilution), including
V-ATP5A (55 kDa), III-UQCRC2 (48 kDa), IV-MTCO1 (40 kDa),
II-SDHB (30 kDa), and I-NDUFB8 (20 kDa). Commercially avail-
able polyclonal antibodies were used to detect voltage-
dependent anion carrier 2 (VDAC 2) (32059, 33 kDa; Santa-
Cruz, 1:1000), adenine nucleotide translocase 1 (ANT 1)
(ab180715, 32 kDa; Abcam, 1:1000), citrate synthase
(ab96600; Abcam, 1:3000), MnSOD (ab13534; Abcam,
1:2000), 4-hydroxynoneonal (4-HNE) (ab46545; Abcam,
1:1000), and sarcomeric s-mtCK (Dr Uwe Schlattner, Greno-
ble, France; 42 kDa, 1:1000). The mtCK antibody has been val-
idated previously to conﬁrm speciﬁcity.50 Protein
carbonylation was detected using the OxyBlot Protein Oxida-
tion Detection Kit (Millipore Sigma, Burlington, MA, USA).
After overnight incubation in primary antibodies, mem-
branes were washed three times, for 5min each time, in TBST
and incubated for 1 h at room temperature with the corre-
sponding infrared ﬂuorescent secondary antibody (LI-COR).
Immunoreactive proteins were detected by infrared imaging
(LI-COR CLx; LI-COR) and quantiﬁed by densitometry (ImageJ,
http://imagej.nih.gov/ij/). All images were normalized to a
whole membrane Amido Black total protein stain (A8181,
Sigma). A double band was detected at 33 kDa for ANT 1 in
skeletal muscle. Similar results were achieved when analysing
either band. As such, the bottom band closer to 33 kDa has
been reported.
Histochemistry
Immediately after removal from the animal, Quad and WG
muscles were embedded in O.C.T compound (Tissue Tek), fro-
zen in liquid nitrogen-cooled isopentane, and stored at80°C
until analysis. Haematoxylin and eosin staining was per-
formed on hindlimb muscle sections (8 μm thickness) to de-
termine average cross-sectional area (CSA) and the area of
necrotic muscle ﬁbres (i.e. ﬁbres with fragmented sarcoplasm
and/or areas of inﬂammatory cells). Three images spaced
evenly throughout the muscle were used for analysis, and a
total of 100 ﬁbres per Quad and 100 ﬁbres per WG were
counted (n = 3 per group). Necrotic area was expressed as a
percentage of the whole muscle section. To determine ﬁ-
brotic area, skeletal muscle sections were stained with
Masson’s Trichrome (ﬁbrotic regions stain blue for collagen)
and expressed as a percentage of the whole muscle section.
Quad and WG sections were imaged Nikon 90i-eclipse micro-
scope (Nikon Inc., Melville, NY) and analysed with the NIS El-
ements AR software (v4.6, Nikon).
For the diaphragm, a piece attached to the rib cage was
immediately placed in 10% neutral buffered formalin for
72 h. After 72 h, the diaphragm was placed in 70% ethanol
where it was preserved until processing using routine proce-
dures. Processed diaphragm was embedded in parafﬁn wax
(Thermo Fisher Scientiﬁc, Burlington, Canada) prior to sec-
tioning (5 μm thickness). Diaphragm sections were stained
with haematoxylin and eosin to measure CSA and necrotic
area, and picrosirius red to measure ﬁbrotic area (ﬁbrotic re-
gions stain red for collagen). Two to ﬁve images (four on av-
erage) were used for diaphragm analyses, and 200–250 ﬁbres
were used to determine CSA (n = 7 per group). Diaphragm
sections were imaged using an Olympus FSX100 light micro-
scope (Olympus, Richmond Hill, Canada) and analysed in
cellSens software (Olympus) for necrosis and ﬁbrosis analysis
or ImageJ (http://imagej.nih.gov/ij/) for CSA analysis.
Statistics
Results are expressed as means ± SEM. The level of signiﬁ-
cance was established as P < 0.05 for all statistics. The
D’Agostino–Pearson omnibus normality test was ﬁrst per-
formed to determine whether data resembled a Gaussian dis-
tribution. Given all data passed normality, parametric tests
were then performed. For all data excluding State III respira-
tion, State III mH2O2 emission, and torque–frequency data,
statistical differences were analysed using unpaired t-tests
between WT and D2.mdx groups, within a given muscle
where applicable. State III respiration, mH2O2 emission, and
torque–frequency curves were analysed within a given mus-
cle (where applicable) using a two-way ANOVA with a main
effect for group being reported (GraphPad Prism Software,
La Jolla, CA, USA).
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Results
Early onset of muscle wasting and weakness in D2.
mdx mice
Body weight was 20% lower in D2.mdx mice (P < 0.05, Figure
1A). Diaphragm ﬁbre CSA was 30% lower in D2.mdx, which
demonstrates muscle atrophy at this young age. (P < 0.05,
Figure 1C). In contrast, D2.mdx Quad CSA was increased by
42% (P< 0.05, Figure 1C) while WG CSA was not different be-
tween groups (Figure 1C) despite a 15% reduction in lower
limb muscle volume (P = 0.07, Figure 1B) suggesting other
lower limb muscles may have been atrophied. Serum creatine
kinase activity was evaluated as a marker of net muscle dam-
age with activity elevated by 392% in D2.mdx mice (P < 0.05,
Figure 1D).
In conjunction with muscle wasting, muscle weakness was
also evaluated through several approaches. Four-week-old
D2.mdx mice demonstrated reduced 24 h voluntary wheel
running (98%, P < 0.05, Figure 1E), cage hang time
(53%, P < 0.05, Figure 1F), and forelimb grip strength
(32%, P < 0.05, Figure 1G). Given the voluntary nature of
these in vivo assays and the potential for neurological contri-
butions to performance, muscle-speciﬁc measurements of
force production were also performed. In vivo force produc-
tion in the hindlimb plantarﬂexors revealed a main effect
for decreases in D2.mdx torque production as a function of
frequency (P < 0.05, Figure 1H) as well as a 13% decrease
in maximum isometric torque (P < 0.05, Figure 1I) compared
with WT. Diaphragm force production, measured through
maximal inspiratory pressures produced during tracheal oc-
clusion, revealed signiﬁcant decreases in D2.mdx pressures
from 15 to 30 s of tracheal occlusion (P < 0.05), but there
were no differences at the earlier time points (0–10 s) of
the occlusion protocol (Figure 1J).
Elevated Complex I-induced mH2O2 during
oxidative phosphorylation in D2.mdx mice
We ﬁrst determined whether the central role of ADP in stim-
ulating respiration and attenuating mH2O2 emission was al-
tered. Complex I-supported respiration and mH2O2 emission
was stimulated with NADH generated by pyruvate (5 mM)
Figure 3 Complex I-supported respiration in D2.mdx mice. State III respiration, supported by complex I substrates pyruvate (5 mM) and malate
(2mM), was assessed in the absence (creatine independent) and presence (creatine dependent) of 20mM creatine at physiological (25 μM), sub-max-
imal (500 μM), and maximal (5000 μM) [ADP]. Assessments of bioenergetic function were completed in diaphragm (A,B), Quad (C,D), and WG (E,F)
muscles. Results represent means ± SEM; n = 8–14; *P < 0.05 compared with wild type (WT).
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and malate (2 mM) in the presence of low/physiological
(25 μM), high sub-maximal (500 μM), and saturating concen-
trations (5mM) of ADP. This titration was repeated with (+Cr)
and without (Cr) 20 mM creatine to drive energy transfer
dependent or independent of mtCK, respectively (as depicted
in Figure 2).
In both Cr and +Cr, ADP-stimulated respiration was de-
creased at various ADP concentrations in diaphragm (12
to 46%), Quad (47 to 72%), and WG (27 to 53%) in
D2.mdx vs. WT (P < 0.05, Figure 3). Similar impairments in
respiration were seen when mtCK ﬂux was maintained by
both PCr and Cr (Supporting Information, Figure S2). mH2O2
was elevated during oxidative phosphorylation in both Cr
and +Cr across low and high [ADP] in D2.mdx diaphragm
(+17 to 88%, P < 0.05), Quad (+19 to 197%, P < 0.05), and
WG (+18 to +74%, P < 0.05) vs. WT (Figure 4).
We also determined the capacity for Complex I-supported
mH2O2 emission in the absence of ADP. This test promotes
maximal electron slip and oxidant generation at Complex I
given ADP is not present to attenuate membrane potential
and promote forward electron ﬂux. As such, the test reveals
the capacity of oxidant generation by Complex I indepen-
dent of the inﬂuence of ADP (State II). Respiration is driven
by proton leak through uncoupling pathways independent of
ATP synthase. Proton leak-dependent respiration trended
lower in D2.mdx diaphragm (31%, P = 0.06) and was
signiﬁcantly lower in D2.mdx Quad (58%, P < 0.05) and
WG (39%, P < 0.05) vs. WT (Supporting Information,
Figure S3A). Concurrent pyruvate/malate-supported mH2O2
in the absence of ADP was unchanged in diaphragm,
elevated by 110% in Quad (P < 0.05), and tended to be
higher in WG (+47%, P = 0.09) vs. WT (Supporting Informa-
tion, Figure S3B).
We then determined the degree to which other pathways
support mH2O2. Complex III (2.5 μMAntimycin A) and pyruvate
dehydrogenase-supported mH2O2 (10 mM pyruvate, 0.5 μM
Rotenone to inhibit Complex I) were decreased in the Quad
(53%, P = 0.05) and WG (60%, P < 0.05), while the dia-
phragm showed a trend for increased Complex III mH2O2
(+35%, P = 0.11) and no differences in pyruvate
dehydrogenase-supported mH2O2 between D2.mdx and WT
(Supporting Information, Figure S4A and S4B). Normalizing
Figure 4 mH2O2 emission during oxidative phosphorylation in D2.mdx mice. State III mH2O2, supported by complex I substrates pyruvate (5 mM) and
malate (2 mM), was assessed in the absence (creatine independent) and presence (creatine dependent) of creatine at physiological (25 μM), sub-max-
imal (500 μM), and maximal (5000 μM) [ADP]. Assessments of bioenergetic function were completed in diaphragm (A,B), Quad (C,D), and WG (E,F)
muscles. Results represent means ± SEM; n = 8–14; *P < 0.05 compared with wild type (WT).
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mH2O2 to Complex III subunit content (Supporting Information,
Figure S4C) or pyruvate dehydrogenase E1α content
(Supporting Information, Figure S4D) altered rates such that
no differences existed in mH2O2 emission in any muscle vs. WT.
Impaired creatine sensitivity in oxidative D2.mdx
muscle
Given impaired bioenergetics were seen in both creatine-
independent and creatine-dependent models of phosphate
shuttling, we also compared whether creatine insensitivity
existed in D2.mdx to gain insight on the role of mtCK in this
disease. As seen in Table 1, at 500 μM ADP, creatine tended
to increase respiration in both diaphragm (+43%, P = 0.06)
and Quad (+57%, P = 0.08) and decreased mH2O2 (diaphragm:
37%, P < 0.05; Quad: 56%, P < 0.01) in WT consistent
with its proposed role in facilitating phosphate shuttling (Fig-
ure 2). In contrast, +Cr had no effect on respiration at 500 μM
in any D2.mdx muscle vs. Cr or on mH2O2 in Quad or WG,
although it lowered mH2O2 in D2.mdx diaphragm (42%,
P < 0.05; Table 1) suggesting mtCK and phosphate shuttling
are impaired in D2.mdx in addition to loss of control by ADP
(Figure 2).
Increased susceptibility to permeability transition
pore opening and elevations in
mitochondria-derived apoptosis in D2.mdx Quad
Previous work has shown that calcium overload leads to PTP
opening more rapidly in dystrophin-deﬁcient diaphragm and
tibialis anterior muscle from C57bl/10-mdx mice.8,51 We next
determined whether reduced calcium retention capacity was
related to the elevated mH2O2 during oxidative phosphoryla-
tion seen in the D2.mdx mice (Figure 5A,B). D2.mdx dia-
phragm and WG muscle showed no differences in the [Ca2+]
required to induce PTP opening vs. WT (Figure 5B) whereas
Quad required 62% less [Ca2+] vs. WT (P < 0.05, Figure 5B).
Caspase 9 activity was also elevated in Quad (+25%,
P < 0.05) suggesting the reduced calcium retention capacity
is related to mitochondrial-induced apoptosis in this muscle
unlike WG (Figure 5C). Interestingly, despite no differences
in calcium retention capacity, caspase 9 activity tended to be
elevated in D2.mdx diaphragm (+43%, P = 0.08; Figure 5C).
These elevations in caspase 9 did not result in activation of
its downstream target, caspase 3, in any muscle (Figure 5D).
Given the decrease in D2.mdx Quad calcium retention ca-
pacity and subsequent increase in mitochondria-derived apo-
ptotic signalling, further analysis of mitochondria structure
and morphology was performed. Because of tissue limita-
tions, the plantaris muscle, which displays a similar ﬁbre type
composition to the vastus intermedius component of the
Quad used for calcium retention capacity,30 was used for
transmission electron microscopy analysis. D2.mdx plantaris
muscle was found to contain swollen mitochondria (Figure
5E), regardless of the mitochondrial location
(subsarcolemmal vs. intermyoﬁbrillar). D2.mdx plantaris mus-
cle also contained less mitochondria per unit area (Figure 5F),
but due to their larger size, no differences in mitochondria
density was evident (Figure 5G).
Increased redox buffering with no change in
markers of cellular oxidative stress in D2.mdx mice
Content of the reduced form of glutathione (GSH) content
was increased in D2.mdx Quad (+55%, P < 0.05) and WG
(+38%, P < 0.05), and tended to be higher in diaphragm
(+8%, P = 0.09), indicative of a compensatory increase in re-
dox buffering (Figure 6A) consistent with increased mH2O2
noted earlier. WG muscle demonstrated elevated levels of ox-
idized glutathione (GSSG) content (+50%, P< 0.05) relative to
WT, while no differences were found in Quad or diaphragm
(Figure 6B). However, total glutathione (GSH + 2×GSSG) was
elevated or tended to be elevated in all muscles (diaphragm:
Table 1. Impairment in creatine sensitivity with 500 μM ADP in DMD
Wild type D2.mdx
Cr +Cr
P-value
(Cr vs. +Cr) Cr +Cr
P-value
(Cr vs. +Cr)
JO2 (pmol·s
1·mg1 wet wt)
Diaphragm 67.2 ± 5.2 95.8 ± 10.2 <0.05 57.6 ± 7.2 63.7 ± 6.4 0.94
Quad 21.2 ± 2.2 33.2 ± 5.5 0.07 12.7 ± 2.1 12.9 ± 2.2 0.53
WG 28.7 ± 3.5 28.1 ± 4.4 0.94 18.9 ± 3.0 16.7 ± 1.1 0.53
mH2O2/O2 consumed
Diaphragm 0.73 ± 0.06 0.53 ± 0.07 <0.05 1.25 ± 0.21 0.72 ± 0.10 <0.05
Quad 1.19 ± 0.11 0.52 ± 0.05 <0.01 1.76 ± 0.26 1.54 ± 0.40 0.64
WG 1.09 ± 0.19 0.72 ± 0.10 0.16 1.46 ± 0.28 1.11 ± 0.25 0.37
Creatine dependent (+Cr), creatine independent (Cr), quadriceps (Quad), white gastrocnemius (WG).
Values represent mean ± SEM (n = 8–14).
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+8%, P = 0.09; Quad: +54%, P < 0.05; WG: +38%, P < 0.05;
Figure 6C) predominately because of increases in reduced
GSH content. Importantly, the ratio of GSH:GSSG was un-
changed in all muscles, suggesting the elevated mH2O2 was
buffered to prevent cellular oxidation at this early time point
(Figure 6D). Indeed, western blotting for lipid peroxidation
(Figure 6E) and protein carbonylation (Figure 6F), indicators
of whole cell oxidative stress, revealed no differences be-
tween D2.mdx and WT muscle. Mitochondrial matrix MnSOD
was lower in Quad (29%, P < 0.05) and WG (22%,
P < 0.05) with no change in diaphragm being observed (Fig-
ure 6G).
Muscle-speciﬁc alterations in key regulators of
energy shuttling
Given the alterations in State III respiration and mH2O2 in
D2.mdx muscle, we next quantiﬁed key regulators of energy
shuttling. ANT 1 and VDAC 2, situated in the inner and
outer mitochondrial membranes, respectively (Figure 2),
were unchanged in diaphragm muscle but were signiﬁcantly
decreased in D2.mdx Quad (ANT 1: 48%, P < 0.05; VDAC
2: 33%, P < 0.05) and WG (ANT 1: 53%, P < 0.05; VDAC
2: 36%, P < 0.05) relative to WT (Figure 7A,B). Similarly,
mtCK content was unchanged in diaphragm but signiﬁcantly
lower in D2.mdx Quad (45%, P < 0.05) and WG (38%,
P < 0.05; Figure 7C). Citrate synthase protein content was
reduced in Quad only (23%, P < 0.05; Figure 7D). Normal-
izing respiration to citrate synthase content (Supporting In-
formation, Figure S5) as validated previously52 generally
did not explain the changes in respiration observed when
normalized per mg weight seen in Figure 3. Quantiﬁcation
of the complexes comprising the electron transport chain
(ETC) was also completed to provide an index of ETC con-
tent. ETC subunit contents were unchanged relative to WT
in both diaphragm (Figure 7E) and WG (Figure 7G) muscle
apart from a decrease in Complex II subunit content in
Figure 5 Evaluation of mitochondrial calcium retention capacity, content, and disbursement. Calcium retention capacity, an index of susceptibility to
permeability transition pore opening (A), was assessed in permeabilized ﬁbres from diaphragm, Quad, and WG muscle (B); n = 6–8. Mitochondrial in-
duction of apoptosis was evaluated through caspase 9 activity (C) followed by its downstream target caspase 3 (D); n = 7. Transmission electron mi-
crographs were acquired in the plantaris muscle and analysed for mitochondrial size (E, mean area, μm2), distribution (F, # per μm2), and density (G,
μm2 × # per μm2 × 100) within the subsarcolemmal (SS) area and intermyoﬁbrillar (IMF) area of the muscle. Representative images (H) demonstrate
the large accumulation of swollen mitochondria (*) in D2.mdx mice relative to the normal conformation of wild type (WT) mitochondria (M); scale
bar = 1 μm, n = 2–3. Results represent mean ± SEM; *P < 0.05 compared with WT.
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D2.mdx diaphragm (15%, P = 0.06; Figure 7E). However,
Quad demonstrated decreases or trends for decreases in
subunit content of Complex I (38%, P < 0.05), II (36%,
P = 0.08), III (34%, P < 0.05), IV (55%, P < 0.05), and
V (19%, P = 0.09) as well as the sum of all ﬁve complex
subunits (37%, P < 0.05; Figure 7F).
Bioenergetic impairments are associated with
elevations in muscle damage in D2.mdx muscle
Muscle-speciﬁc membrane damage was evaluated though Ev-
ans Blue Dye staining in a separate subset of animals. Sixteen
hour post injection of 1% Evans Blue Dye, animals were
sacriﬁced, and muscle was visually inspected for dye uptake.
Dye uptake, which occurs in muscles with damaged cell mem-
branes,53 was evident in the Quad, WG, and tricep brachii
muscles with minimal uptake occurring in the soleus,
plantaris, extensor digitorum longus, and the tibialis anterior.
A striated pattern of dye uptake was evident in the dia-
phragm muscle (Supporting Information, Figure S1).
Necrotic area was elevated in diaphragm (5.5% vs. 0% of
total area vs. WT, P < 0.05; Figure 8A), Quad (31.8% vs.
0.6%, P < 0.05; Figure 8B), and WG (48.2% vs. 0.2%,
P = 0.06; Figure 8C). Fibrotic area was also elevated in dia-
phragm (12.7% vs. 8.4% of total area vs. WT, P < 0.05; Figure
8D), Quad (17.0% vs. 6.3%, P < 0.05; Figure 8E), and WG
(22.0% vs. 3.5%, P < 0.05; Figure 8F).
Discussion
Oxidative stress has long been implicated as a contributor to
the myopathy of DMD. However, identifying the precise
source of elevated oxidants has remained controversial. In
this study, we demonstrate that mH2O2 is elevated concur-
rent with impaired oxidative phosphorylation speciﬁc to Com-
plex I-supported respiration. An impairment in the ability of
ADP to both stimulate respiration and attenuate mH2O2
was central to these impairments. These bioenergetic deﬁcits
occurred early in the disease process (4 weeks of age) and
were associated with severe myopathy in skeletal muscles
Figure 6 Evaluation of redox buffering capacity and whole cell oxidative status. Glutathione was measured in muscle homogenate using HPLC-UV for
the detection of GSH (A) and HPLC-ﬂuorescence for the detection of GSSG (B). The GSH:GSSG ratio (C) and total glutathione (D) were calculated from
GSH and GSSG measurements; n = 6. Whole muscle lysate was used for the quantiﬁcation of proteins modiﬁed through lipid peroxidation (E) and car-
bonylation (F) as well as the quantiﬁcation of protein content of MnSOD (G); n = 6–8. Results represent mean ± SEM;
*
P < 0.05 compared with wild
type (WT).
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and diaphragm. By identifying a potential new relationship
between elevated mH2O2, impaired oxidative phosphoryla-
tion and myopathy in diaphragm (respiratory) and limb mus-
cle (locomotor; see summary Figure 9), these ﬁndings suggest
that DMD may be a candidate for therapeutics that attenuate
mH2O2
54 and improve mitochondrial respiratory control.
Several factors warranted a re-evaluation of mH2O2 in
DMD. First, an elegant study by Godin et al.8 demonstrated
an unexpected decrease in mH2O2 in the tibialis anterior of
the classic C57bl/10-mdx mouse, but this occurred concur-
rently with increased redox buffering capacity suggesting
compensation occurred in response to an underlying redox
stress.8 Furthermore, the degree of mitochondrial dysfunc-
tion may differ across muscles in relation to the extent of my-
opathy that warrants comparisons of muscle types,
particularly given the known regenerative capacities of the
classic C57bl/10-mdx model.55,56 The design of in vitro proto-
cols to measure mitochondrial respiration and mH2O2 must
also be considered given (i) ADP governs both processes con-
currently, (ii) disease-related stressors may alter sensitivity to
low ADP concentrations to a different extent than saturating
conditions, (iii) mitochondrial-cytosolic energy exchange is
thought to occur through either direct ADP/ATP cycling or
Cr/PCr shuttling via mtCK, and (iv) there are multiple sources
of oxidant generation that contribute to net mH2O2. By
controlling for these factors, a general pattern of impaired
Complex I activity, creatine insensitivity, and ADP insensitivity
in the regulation of mH2O2 and respiration was identiﬁed in
both dystrophic respiratory and locomotor muscles.
Concurrent impairments in Complex I and
governance by adenosine diphosphate
At 4 weeks of age, D2.mdx diaphragm, Quad, and WG muscle
exhibit elevated Complex I-supported mH2O2 during oxidative
phosphorylation. This pattern appeared to be due to several
factors. First, the maximal rate of mH2O2 supported by Com-
plex I was increased as seen in the absence of ADP’s inﬂuence
on membrane potential (State II conditions). The impair-
ments at Complex I were not explained by altered protein
content of the NDUFB8 subunit. This suggests post-
translational modiﬁcations may have occurred. Indeed, Com-
plex I activity can be decreased by oxidation of speciﬁc cyste-
ine residues57 but the degree to which this occurs in DMD
remains to be determined. Also, while superoxide production
prior to dismutation to H2O2 was not assessed, the increases
in H2O2 emission during respiration are suggestive of in-
creased superoxide production particularly given MnSOD
was lower in Quad and WG. It is also possible that the lower
Figure 7 Muscle-speciﬁc changes in essential regulators of bioenergetics in D2.mdx mice. Protein content of adenine nucleotide translocase 1 (ANT 1)
on the inner mitochondrial membrane (A), voltage-dependent anion carrier 2 (VDAC 2) on the outer mitochondrial membrane (B), mitochondrial cre-
atine kinase (mtCK) found in the inner membrane space (C), and citrate synthase that catalyses the ﬁrst reaction in the citric acid cycle (D). Protein
content of electron transport chain components was also quantiﬁed in diaphragm (E), Quad (F), and WG (G). Results represent mean ± SEM;
n = 8–12; *P < 0.05 compared with wild type (WT).
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leak respiration in the absence of ADP reﬂects less
uncoupling, which may contribute to elevated membrane
potential-dependent Complex I superoxide production.18
Furthermore, low/physiological to high concentrations of
ADP were unable to attenuate mH2O2 to the same extent
as WT. The impaired control by ADP in skeletal muscle may
not be related to changes in mitochondrial content given
ETC markers were unchanged in diaphragm and WG similar
to what has been reported recently in C57bl/10-mdx mouse
soleus and extensor digitorum longus.58 Rather, this may be
explained partially by limited ADP/ATP exchange due to de-
creased protein expression of VDAC 2 and ANT 1 in Quad
and WG, or octameric mtCK, the regulator of high energy
phosphate shuttling. There was no change in the content of
these proteins in diaphragm, which suggests that post-
translational regulation of these proteins may have been al-
tered. Indeed, all three proteins are redox sensitive.59–61
ANT and VDAC also have known phosphorylation sites62,63 al-
though the physiological relevance of this regulatory para-
digm remains unknown. Furthermore, mtCK is highly
susceptible to oxidative modiﬁcations, leading to enzymatic
inactivation and octamer dissociation, as well as formation
of crystalline mitochondrial inclusion bodies, all resulting in
loss of function.64,65 The present ﬁndings suggest future ex-
amination of post-translational regulation of Complex I,
isoforms of ANT 1 and VDAC 2, as well as mtCK may reveal
how multiple cellular stressors in DMD lead to the observed
mitochondrial dysfunctions. Lastly, while no other site of mi-
tochondrial oxidant generation tested in this investigation
demonstrated altered mH2O2 (reverse electron ﬂux from
Complex II, Complex III, and pyruvate dehydrogenase), addi-
tional sites could be considered in future investigations at this
early age.66,67
To our knowledge, this is the ﬁrst study to demonstrate
impairments in ADP-stimulated respiration at both low and
maximal kinetics in D2.mdx diaphragm muscle. The respira-
tory impairments in Quad and WG are consistent with previ-
ous reports in humans15,17 and C57bl/10-mdx skeletal
muscle.8,15,16,68 However, the role of creatine-dependent
phosphate shuttling through mtCK was not assessed, which
means these earlier studies only report impairments in
creatine-independent ADP/ATP cycling similar to the present
ﬁndings, albeit with one exception that also reported im-
paired creatine sensitivity in oxidative muscles.69 Given the
creatine-dependent model is predicted to be the dominant
system of energy exchange,22 the lack of effect of creatine
on respiration in D2.mdx may be particularly detrimental to
muscle function, in particular, at high workloads with re-
peated contractions (Table 1). As noted earlier, changes in
ANT 1, VDAC 2, and mtCK might contribute to this loss of
Figure 8 Quantiﬁcation of muscle damage in D2.mdx mice. Necrosis was evaluated in diaphragm (A), Quad (B), and WG (C) using haematoxylin and
eosin (H&E) staining in all muscles. Fibrosis was evaluated in diaphragm (D) using picrosirius red and in Quad (E) and WG (F) using Masson’s trichrome.
Results represent mean ± SEM; n = 3–6; *P < 0.05 compared with wild type (WT). Representative images of diaphragm (G, magniﬁcation, ×40), Quad
(H, magniﬁcation, ×20), and WG (I, magniﬁcation, ×20).
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control by ADP in Quad and WG, but alternative mechanisms
are likely for diaphragm, further highlighting the importance
of considering post-translational modiﬁcations.
Possible relationships between mitochondrial
bioenergetics and myopathy in Duchenne muscular
dystrophy
Mitochondrial induction of apoptosis and necrosis has been
linked to several diseases that also exhibit elevated mitochon-
drial ROS and impaired oxidative phosphorylation.70–75 It is
thought that impairments in both processes can contribute
to the induction of PTP formation as can occur under condi-
tions of calcium overload.76 Such PTP formation has already
been implicated in DMD myopathy in response to calcium
stress.8,51 However, the synergistic link with mH2O2 had not
been demonstrated. Indeed, an increase in mitochondrial
[Ca2+] alone is relatively ineffective at inducing PTP forma-
tion, but mitochondrial sensitivity to [Ca2+] can be drastically
increased through elevated ROS.77 Furthermore, the in-
creases in caspase 9 seen in Quad are consistent with previ-
ous reports of greater cytochrome c release in dystrophic
muscle78—a process that is known to be triggered in part
by mitochondrial ROS during induction of the PTP.79 Overall,
the present ﬁndings suggest that elevated mH2O2 contributes
to this calcium-overload induction of PTP in Quad but not
necessarily in diaphragm or WG at this early stage of the dis-
ease (Figure 4). Surprisingly, Quad displayed hypertrophy
based on ﬁbre CSA, which may be compensation to caspase
9-mediated cell death. Indeed, this early hypertrophy is con-
sistent with observations in Quad of young boys with DMD
that was later followed by atrophy in advanced stages of
the disease.80
In contrast to the present study, previous work has
shown heightened sensitivity to Ca2+-induced PTP in
diaphragm in C57bl/10-mdx mice. Methodological differ-
ences may contribute to these divergent ﬁndings as previous
studies have produced divergent results depending on
whether PTP opening was assessed in terms of elapsed time
in response to a single bolus of Ca2+51 or identifying the min-
imal concentration required to trigger PTP as in the present
study.8,51 These discrepant ﬁndings suggest the approach
used to determine PTP sensitivity to Ca2+ can change the
conclusion and that comparison to other proxies of PTP are
warranted.
Figure 9 Summary of the relationship between impaired mitochondrial bioenergetics and myopathy in Duchenne muscular dystrophy (DMD). Speciﬁc
dysfunctions in Complex I and central respiratory control by ADP and creatine cause elevated oxidant generation during impaired oxidative
phosphorylation in association with a loss of muscle force.
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It is possible that calcium-independent modulators of mi-
tochondrial dysfunction and induction of cell death are pres-
ent in DMD. While not assessed in this study, mH2O2 also
activates necrosis in a PTP-independent manner by activating
nuclear factor-kappa B (NF-κB)81 and up-regulating the pro-
inﬂammatory cytokine tumour necrosis factor-alpha (TNF-
α).82,83 Indeed, antioxidants that lower mH2O2 have been
shown to prevent muscle wasting in a TNF-α induced model
of cachexia,84 and an anti-TNF-α antibody (Remicade) reduces
muscle necrosis and inﬂammation in C57bl/10-mdx mice.85
Further examination of alternative mechanisms by which im-
paired mitochondrial bioenergetics contributes to cell death
in DMD may be fruitful considering the necrosis observed in
the present study (diaphragm, WG, and Quad) was not con-
sistently linked to a calcium-induction of PTP, particularly in
diaphragm that displayed atrophy without caspase 9
activation.
Perspectives on redox homeostasis in Duchenne
muscular dystrophy: reconciling with previous
literature
While cytoskeletal-based NADPH oxidase activity is increased in
dystrophin-deﬁcient mouse skeletal muscle,86 the contribution
of mitochondrial-speciﬁc ROS across all muscle types has re-
ceived surprisingly little attention. To our knowledge, only
one previous study has directly measured mH2O2 in skeletal
muscle of dystrophin-deﬁcient mice. Using tibialis anterior mus-
cle from 6-week-old C57bl/10-mdx mice, Godin et al. demon-
strated a surprising decrease in mH2O2.
8 This decrease
appeared to be due to increases in mH2O2 scavenging capacity
that may be related to extensive muscle regeneration at this
age in C57bl/10-mdx mice that occurs after an earlier period
of peak necrosis at 3–4weeks.55,56 This robust increase in scav-
enging capacity may reﬂect a compensation in response to an
underlying elevation inmH2O2. As such, we re-evaluated the re-
lationship between mH2O2 and myopathy in a model with less
regenerative capacity25,26 and in muscles displaying membrane
damage (Supporting Information, Figure S1). While a direct
comparison of mitochondrial bioenergetics in muscles with
and without damaged cell membranes was not performed, het-
erogeneous rates and degrees of myopathy between muscles
should be taken into consideration when evaluating the contri-
bution of the mitochondria to the myopathy. It is also possible
that the differences between these previous observations and
the present investigation may be due to the age (6 vs. 4 weeks
currently) or the muscle analysed (tibialis anterior previously),
but this remains to be determined.
Contrary to previous work in young C57bl/10-mdx mice
that showed a more oxidized GSH:GSSG ratio,87,88 the pres-
ent investigation revealed no changes in the glutathione ratio
in all muscles analysed. Despite the differences in mH2O2
emission rates, both the present study and the work by Godin
et al. demonstrate increases in redox buffering capacity. Sim-
ilarly, in accordance with previous ﬁndings,8,88 no differences
in lipid peroxidation were detected through 4-HNE or protein
carbonylation levels between WT and D2.mdx muscles. These
results suggest that the increases in buffering capacity are
sufﬁcient to tolerate the stress created by elevated mH2O2
and prevent detectable oxidative damage from occurring at
this early time point. However, it is plausible that the buffer-
ing capacity of the cell will become overwhelmed and result
in oxidative damage as the disease progresses. Furthermore,
4-HNE and carbonylation are measures of irreversible oxida-
tive damage, and therefore, the present investigation does
not rule out H2O2 acting as a reversible redox signal within
the cell. Future investigation into the time-course of redox
stress in the context of both reversible and irreversible mod-
iﬁcations in this D2.mdx model of DMD are warranted.
Conclusions
In summary, this investigation identiﬁed elevations in Com-
plex I-supported mH2O2 during oxidative phosphorylation
concurrent with impaired ADP and creatine control of respira-
tion in D2.mdx diaphragm, Quad, and WG muscle. These im-
pairments were associated with a greater propensity for
calcium-induced PTP and caspase 9 activation in Quad, but
the degree to which they are related to apoptosis in other
muscles requires further investigation. The potential associa-
tion between these mitochondrial impairments and myopa-
thy at an early stage of DMD may guide the pre-clinical
testing of mitochondrial-targeted therapeutics to restore nor-
mal mH2O2 and Complex I-supported oxidative phosphoryla-
tion, particularly by rescuing ADP and creatine control of
bioenergetics. While such an approach would not target the
primary cause of the disease, the addition of mitochondrial
therapies warrants consideration given existing standards of
care already focus on treating other secondary complications
of DMD in the absence of genetic therapies.
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Figure S1. Evaluation of sarcolemmal damage by Evans Blue
Dye staining in D2.mdx. Representative images of Evans Blue
Dye (EBD) staining in WT and D2.mdx skeletal muscles
16 hours following an injection of 1% EBD solution at 5 μl/g
body weight.
Figure S2. ADP-stimulated respiration in the presence of
phosphocreatine and creatine. 13.9 mM phosphocreatine
(PCr) and 9.1 mM creatine (Cr) were added to the assay me-
dia to assess state III respiration supported by Complex-I sub-
strates pyruvate (5 mM) and malate (2 mM) in Diaphragm
(A), Quad (B) and WG (C). Results represent mean ± SEM;
n = 10–12; * p < 0.05 compared to WT.
Figure S3. Evaluation of state II respiration and mH2O2. State
II (no ADP; proton leak) respiration (A) and mH2O2 emission
(B) were initiated using Complex-I substrates pyruvate
(5mM) and malate (2mM) in Diaphragm, Quad and WG mus-
cles. Results represent mean ± SEM; n = 10–12; * p < 0.05
compared to WT.
Figure S4. Additional sites of state II mH2O2 emission. Com-
plex-III derived mH2O2 was assessed using Complex-III inhibi-
tor antimycin A (2.5 μM). Data was expressed per mg muscle
weight (A) as well as normalized to Complex-III content (B).
Pyruvate dehydrogenase complex (PDC) derived mH2O2 was
assessed using pyruvate (10 mM) and Complex-I inhibitor ro-
tenone (0.5 μM). Data was expressed per mg muscle weight
(C) as well as normalized to PDH-E1α content (D). Results rep-
resent mean ± SEM; n = 8–12; * p < 0.05 compared to WT.
Figure S5. Intrinsic Respiratory Capacity. State III respiration,
supported by Complex-I substrates pyruvate (5 mM) and ma-
late (2 mM), was assessed in the absence (Creatine Indepen-
dent) and presence (Creatine Dependent) of 20 mM creatine
at physiological (25 μM), sub-maximal (500 μM) and maximal
(5000 μM) [ADP] and normalized to citrate synthase content.
Assessments of bioenergetic function were completed in Dia-
phragm (a-b), Quad (c-d) and WG (e-f) muscles. Results repre-
sent means ± SEM; n = 5–8; * p < 0.05 compared to WT.
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